Anders Essen-Möller

Anders Essen-Möller is a declared insider at 2 companies (board member); the most frequent names are Diamyd Medical AB and Diamyd Medical Aktiebolag. In total, 6 filings cover trades dated from 3 February 2021 to 27 July 2026.

On the open market, the record shows 3 purchases worth €37k and 1 sale worth €116k. Taken together, the sales exceed the purchases by €79k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 share grants. So far in 2026, the count stands at 3 purchases and no sales.

A typical purchase (the median) is worth €8,971. Scaled by market value, the purchases weigh a median 0.063% of market cap (sample: 3 purchases). None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The record was last updated on 27 July 2026 with an open-market purchase (€8,799) in Diamyd Medical Aktiebolag. Most trades are made public on the day they happen. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.